Clinical Trial Update: A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating camrelizumab for colorectal mucinous adenocarcinoma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN